Shares of Cardinal Health Inc. CAH rose 1.05% to $135.84 Thursday, on what proved to be an all-around positive trading ...

Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Explore 24 Grados’ approach to architecture, restoring heritage and community through thoughtful design in Honduras.

Cardinal Health (CAH) closed the most recent trading day at $133.69, moving +1.92% from the previous trading session.

Valued at a market cap of $31.7 billion, Dublin, Ohio-based Cardinal Health, Inc. (CAH) is one of the largest U.S.

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

We recently published a list of Jim Cramer’s List of 16 Stocks to Buy Right Now. In this article, we are going to take a look ...

Yes, I do think we need non-glucocorticoid forms of therapy to treat 21-hydroxylase deficiency congenital adrenal hyperplasia.The most common form of congenital adrenal hyperplasia (CAH) is a ...

Medical leaders are worried about potential cuts to Critical Access Hospitals (CAH), a special designation given by the ...

FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that its Board of Directors has approved a 1 for 10 reverse stock split of the Company’s Class A common stock, ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The ...